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Abstract: Hyaluronic acid (HA) is a biopolymer formed by UDP-glucuronic acid and UDP-N-acetyl-
glucosamine disaccharide units linked by β-1,4 and β-1,3 glycosidic bonds. It is widely employed
in medical and cosmetic procedures. HA is synthesized by hyaluronan synthase (HAS), which
catalyzes the precursors’ ligation in the cytosol, elongates the polymer chain, and exports it to
the extracellular space. Here, we engineer Ogataea (Hansenula) polymorpha for HA production by
inserting the genes encoding UDP-glucose 6-dehydrogenase, for UDP-glucuronic acid production,
and HAS. Two microbial HAS, from Streptococcus zooepidemicus (hasAs) and Pasteurella multocida
(hasAp), were evaluated separately. Additionally, we assessed a genetic switch using integrases in
O. polymorpha to uncouple HA production from growth. Four strains were constructed containing
both has genes under the control of different promoters. In the strain containing the genetic switch,
HA production was verified by a capsule-like layer around the cells by scanning electron microscopy
in the first 24 h of cultivation. For the other strains, the HA was quantified only after 48 h and in
an optimized medium, indicating that HA production in O. polymorpha is limited by cultivation
conditions. Nevertheless, these results provide a proof-of-principle that O. polymorpha is a suitable
host for HA production.
Keywords: Ogataea polymorpha 1; hyaluronic acid 2; methylotrophic yeast 3; genomic editing 4;
genetic switch 5; promoters 6
1. Introduction
Microorganisms have been widely used to obtain pharmaceuticals, biopolymers, vac-
cines, enzymes, and various other chemicals [1]. Through metabolic engineering and
synthetic biology approaches, it is possible to generate recombinant strains to produce
desired compounds and bypass the chemical synthesis [2]. One of the value-added prod-
ucts that can be obtained through microorganism-based processes is hyaluronic acid (HA).
This biopolymer features high viscosity and elasticity and is abundant in the extracellular
matrix of vertebrates’ connective tissues. Due to its high biocompatibility, HA has various
applications in the medical, cosmetic, and pharmaceutical areas (see details in [3]). Accord-
ing to Grand View Research Inc., the global HA market may reach USD 16.6 billion by
2027 [4].
HA is a glycosaminoglycan formed by disaccharide repeats of UDP-glucuronic acid
(UDP-GlcUA) and UDP-N-acetylglucosamine (UDP-GlcNAc) linked by β-1,4 and β-1,3
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glycosidic bonds [5]. Its synthesis is catalyzed by the enzyme hyaluronan synthase (HAS),
encoded by the gene hasA, and responsible for assembling the two precursors in the cytosol,
elongating the polymer chain and releasing it into the extracellular matrix. Gram-positive
bacteria and yeasts are the most used microorganisms for producing heterologous HA,
especially those with Generally Recognized as Safe (GRAS) status. Many such strains
have been developed in recent years, using different approaches to improve HA titers [6].
Bacillus subtilis [7,8], Corynebacterium glutamicum [9], and Lactococcus lactis [10] are the
main bacteria used for the production of this polymer. Bacteria possess the complete
pathway for the synthesis of both precursors, whereas yeasts are only naturally capable of
synthesizing UDP-GlcNAc. Thus, in addition to hasA, HA production in yeast cells requires
the expression of the hasB gene, which encodes the UDP-glucose 6-dehydrogenase needed
for UDP-GlcUA synthesis (Figure 1). To the best of our knowledge, only two yeasts have
been engineered for HA production so far: Kluyveromyces lactis [11] and Komagataella phaffii
(previously known as Pichia pastoris) [12]. Here, we describe the heterologous production
of HA by Ogataea (Hansenula) polymorpha.
Figure 1. Biosynthetic pathway for hyaluronic acid (HA) production in Ogataea (Hansenula) polymorpha. The black and
blue arrows indicate the endogenous glycolysis and HA precursor pathways, respectively. The green arrows indicate the
exogenous pathway inserted in O. polymorpha for HA production. The red arrows represent methanol metabolism. Genes
encoding enzymes of the pathways are shown: aox: alcohol oxidase; cat: catalase; dhas: dihydroxyacetone synthase; dak:
dihydroxyacetone kinase; hxk: hexokinase; pgi: glucose-6-phosphate isomerase; pfk: phosphofructokinase; fbp: fructose-1,
6-bisphosphatase; fba: fructose-bisphosphate aldolase; pgmA: phosphoglucomutase; hasC: UDP-glucose pyrophosphorylase;
hasB: UDP-glucose dehydrogenase; glmS: amidotransferase; glmM: phosphoglucosamine mutase; hasD: acetyltransferase
and UDP-N-acetyl-glucosamine pyrophosphorylase; hasA: hyaluronic acid synthase. Molecules: DHA: dihydroxyacetone;
DHAP: dihydroxyacetone phosphate; GAP: glyceraldehyde-3-phosphate; Xu-5P: xylulose-5-phosphate; FBP: fructose-1,
6-bisphosphate; Glucose-6P: glucose-6-phosphate; Fructose-6P: fructose-6-phosphate; Glucose-1P: glucose-1-phosphate;
UDP-glcUA: UDP-glucuronic acid; GlcN-6P: glucosamine-6-phosphate; GlcN-1P: glucosamine-1-phosphate; GlcNAc-1P:
N-acetyl-glucosamine-1-phosphate; UDP-GlcNAc: UDP-N-acetyl-glucosamine; HA: hyaluronic acid.The methylotrophic
yeast O. polymorpha (formerly known as Hansenula polymorpha or Pichia angusta) is used as an expression platform because of
its features, which include fermentation at high cell densities, low-cost substrate utilization, defined synthetic medium,
secretion of heterologous proteins in high levels, established strategies for bioreactor cultivation, and availability of synthetic
biology tools for genetic manipulation [13]. O. polymorpha is widely used to produce biopharmaceuticals, including
Insulin (Wosulin®), α-Interferon (Reiferon®), and others [14], and therefore it is an attractive host platform to produce HA.
Furthermore, this non-conventional yeast is thermotolerant, and this can be explored for HA production, as it was recently
reported that temperature changes affect the chain length of HA as well as the titers [15]. In B. subtilis, an increase in the
cultivation temperature led to an increase in HA’s molecular weight but a decrease in its concentration in the culture broth.
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In terms of available genetic tools, a set of endogenous promoters was previously
described for O. polymorpha with different regulatory mechanisms that allow for developing
strategies to regulate gene expression [16]. As a methylotrophic yeast, many of these charac-
terized promoters are related to methanol metabolism, controlling the expression of genes
encoding enzymes required to metabolize methanol. Additionally, promoters regulating
genes related to nitrate metabolism and inducible by this nitrogen source (YNR1 [17] and
YNI1 [18]) as well as related to temperature increase (TPS1 and HSA1 [19]) were described
in O. polymorpha. Although a set of promoters is available for this non-conventional yeast,
the methanol-inducible one is preferred to control heterologous gene expression. Culti-
vation strategies using these promoters usually are based on two phases, although other
approaches based on derepression of these promoters were also reported [20]. The first
step is the growth phase, which focuses on biomass production using glucose or glycerol,
followed by a methanol induction phase to produce the heterologous protein. Therefore,
the utilization of methanol-inducible promoters allows developing strategies that decouple
growth and product synthesis, because in the absence of methanol no significant levels
of heterologous protein are achieved. Such decoupled strategies are advantageous for
synthesis of compounds which metabolic pathways compete with biomass production,
such as HA.
In O. polymorpha, the promoter which controls the methanol oxidase gene (pMOX, also
referred as pAOX, since the methanol oxidase is the primary alcohol oxidase described in
this organism [17]) is preferred for heterologous gene expression [21], and its regulatory
mechanisms are widely studied [22]. Although it is mainly regulated by methanol and
repressed by glucose, it is active under limiting-glucose conditions [23], leading to promoter
leakage, which might affect strategies that require gene regulation. Additionally, pMOX is
derepressed in the presence of other carbon sources such as glycerol, xylose, ribose, and
sorbitol [24]. Other promoters upregulated by methanol and repressed by glucose include
pDHAS (dihydroxyacetone synthase) and pFMD (formaldehyde dehydrogenase) [25]. The
latter is an alternative to pMOX since it is considered a strong promoter in the presence
of methanol. However, a high level of enzyme production (13.5 g/L) has been achieved
using glucose as the carbon source [26]. For HA production, the utilization of methanol-
inducible promoters is a feasible strategy to avoid competition between its synthesis and
biomass production, which is the main limitation for the heterologous production of HA
(Figure 1) [27,28].
Although methanol-inducible promoters are widely used in heterologous protein
expression by O. polymorpha, their use may be discouraged due to its leakage under
some carbon sources and methanol toxicity and flammability, especially at an industrial
scale. Thus, promoters regulated by other inducers or constitutive promoters are available
alternatives. The strong constitutive pGAP promoter is commonly used for gene regulation
in O. polymorpha [29]. Other endogenous constitutive promoters already described for this
yeast include pTEF1 [13] and pADH1 [30]. However, this type of promoter does not allow
one to tune gene regulation, and the heterologous protein is produced similarly regardless
of cultivation conditions. Therefore, an alternative genetic tool must be considered for
tunning gene regulation. For example, the utilization of genetic switches such as serine
integrases enables the building of genetic circuits through targeted DNA rearrangement.
If two recognizing sites (attB and attP) are inserted flanking the desired DNA sequence,
the integrase is capable of identifying these sites and flip the sequence at 180◦ (see details
in [31]). Thus, this strategy works as a genetic tool for gene regulation once any genetic
element (promoter, coding sequence, and/or terminator) can be constructed flanked by
these att sites. The rotation of the desired DNA sequence can occur in a specific condition.
Recently, a system using the sites attB and attP and different serine integrases was applied
to build a genetic switch in other eukaryotic cells [32].
In this work, the genetic modifications necessary for the heterologous production of
HA using O. polymorpha as a chassis organism are described (Figure 1). For this, the hasA
and hasB genes were integrated into the O. polymorpha genome under different promoters’
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regulation. Various combinations were tested to evaluate their influence on HA titers. Two
hasA genes were used, referred to as hasAs (from Streptococcus zooepidemicus) and hasAp
(from Pasteurella multocida). The hasAp gene was evaluated because, as with the hasB (from
Xenopus laevis) used, we previously demonstrated that the enzymes encoded by these genes
were active in K. lactis, another non-conventional yeast [11]. The hasAs was selected since it
is widely used for heterologous production of HA [7,33,34].
Moreover, to better control HA production, we have also employed a genetic switch
using a serine integrase to control both hasAp and hasB gene expression. The integrase-13
(Int13) was selected due to its versatility, successfully applied to design genetic switches
in human, bovine, and plant cells [32]. Besides, no point mutations or changes in cell
viability caused by the Int13 were detected in cells analyzed in the previous study. Thus,
we evaluated a genetic switch using the Int13 as a proof-of-concept in O. polymorpha to
control the expression of both hasB and hasAp genes aiming at HA production by this yeast.
A capsule-like layer could be seen around cells of the strain containing the genetic switch
controlling hasB and hasAp expression named here as EMB103, using a scanning electron
microscopy analysis. In the other strains expressing only hasB and hasA, the cell surface
was similar to the wild-type strain. However, after 48 h of cultivation in an optimized
medium, HA was quantified from the culture broth of all three constructed strains tested.
This is the first report of an O. polymorpha strain developed for HA production to the best
of our knowledge.
2. Materials and Methods
2.1. Chemicals and Molecular Biology Procedures
Ampicillin, hygromycin, zeocin, and analytical grade HA for quantification standards
were purchased from Sigma-Aldrich. T4 DNA Ligase, Taq DNA polymerase, and restriction
endonucleases were from Thermo Fisher. The hasB (GenBank accession number MH728986),
hasAp (GenBank accession number MH728990), and hasAs (GenBank AF414053.1) genes
were each synthesized and delivered in pBSK plasmids by Síntese Biotecnologia, which
also supplied DNA oligonucleotides. The genes hasB and hasAp were selected from a
previous study [11]. The nucleotide sequence for all genes is shown in Supplementary
Materials, Sequence S1–S3). The pGEM-T Easy vector, used in cloning procedures, was
purchased from Promega (Madison, WI, USA).
General molecular biology procedures were conducted according to Sambrook and
Russel [35]. All reagents and kits were supplied by Thermo Fisher (Waltham, MA, USA)
and used according to their recommendations. The primers used in this study are shown
in Table S1. PCR products were purified using the GeneJet PCR Purification Kit from Ther-
mofisher, and fragments treated with restriction enzymes were recovered from agarose gels
0.8% using the GeneJET Gel Extraction Kit. Plasmid cloning was carried out using T4 DNA
Ligase after treating inserts and vectors with appropriate restriction endonucleases. Trans-
formation of Escherichia coli through heat shock was performed as described previously [36].
Plasmids were extracted using the GeneJet Plasmid Miniprep Kit from Thermofisher.
2.2. Construction of Plasmids and Strains
The plasmids and strains used in this study are listed in Tables S2 and S3, respectively.
Sequences of constructed plasmids are shown in Supplementary Materials, Sequences
S5–S11. The O. polymorpha strain NCYC495 yku80 was used and is referred to as Wild
Type (WT). This strain, in which the gene encoding KU80 protein was deleted to diminish
recombination by non-homologous end joining (NHEJ), and the plasmids of the pHIP
series, used as backbone vectors, were cordially provided by Dr. Ida J van der Klei [37].
The E. coli DH10B strain (Thermo Fisher) was used for plasmid cloning and expansion. All
plasmids were confirmed by restriction enzyme analysis and PCR. In total, four strains of O.
polymorpha were constructed from the NCYC495 yku80 strain. The overall strategy for strain
construction and the final strain genotypes are summarized in Figure 2 and described in
the Supplementary Materials. Stability of construct integration was confirmed thoroughly
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throughout the study through PCR of colonies resulting from consecutive passaging on
selective media plates.
Figure 2. Strains constructed in this study to evaluate HA production in O. polymorpha. Light blue arrows represent
transformation events with the plasmids specified. Integration of plasmids by single crossover is depicted. Hyg: hygromycin
resistance cassette. Zeo: zeocin resistance cassette.
To construct the pHIPH4_hasB vector, the hasB gene was amplified from pBSK_hasB
using the primers described in Table S1. Amplification added sites for the restriction
enzymes HindIII and SalI to the hasB amplicon, which was then ligated into pGEM-T
Easy. The resulting pGEM_hasB vector and pHIPH4 were treated with HindIII and SalI.
The fragment containing hasB was purified from an agarose gel for ligation into pHIPH4
between pAOX and the Tamo terminator, resulting in the pHIPH4_hasB vector. Similarly,
the hasAp gene was extracted from the pBSK_hasAp vector using HindIII and XhoI, which
were also used to remove eGFP-SKL from the pHIPZ18_eGFP-SKL vector. The hasAp
fragment and the pHIPZ18 backbone were purified from an agarose gel. The former was
then ligated between the pADHI promoter and the Tamo terminator of the latter, resulting
in the pHIPZ18_hasAp vector. The pHIPH4_hasB and pHIPZ18_hasAp plasmids were
inserted into strain NCYC495 yku80, resulting in the strain EMB101 (Figure 2).
To construct pHIPZ7_hasAp, the pHIPZ18_hasAp and pHIPZ7 vectors were treated
with HindIII and XhoI and cloned as described above pHIPZ7_hasAp, which has the hasAp
gene under the control of pTEF1 and Tamo terminator. The strain containing the hasB gene
was transformed with pHIPZ7_hasAp, resulting in EMB102 (Figure 2).
The whole pHIPH4_ScSInt13 plasmid was designed to contain a genetic switch con-
trolling the expression of hasAp and hasB. The pHIPH4 plasmid was used as a backbone
to construct a vector bearing a gene encoding a serine-type phage integrase-13, codon-
optimized for S. cerevisiae, and the same hasAp and hasB expression cassettes as in the
pHIPZ18_hasAp and pHIPH4_hasB plasmids. The Integrase13 target sites attB and its re-
verse complement sequence attP [38,39] were placed flanking both with genes synthesized
in reverse complement orientation [25,26]. The nucleotide sequence for the integrase-13
and the sequences of attB and attP was based on a previous study [40]. The whole plasmid
was synthesized by Epoch Life Science Inc (Missouri City, TX, USA) and confirmed by
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sequencing and restriction enzyme analysis. It was linearized in the pAOX promoter and
transformed into NCYC495 yku80 to generate EMB103 (Figure 2).
The pHIPZ18_hasB plasmid was constructed using HindIII and XbaI to excise hasB
from pHIPH4_hasB and insert it into the pHIPZ18 vector treated with the same enzymes.
Fragment and backbone were gel-purified before ligation. The same restriction enzymes
were used to generate the pHIPH4_hasAs plasmid by cloning hasAs from pBSK_hasAs
into the pHIPH4 backbone. Strain NCYC495 yku80 was transformed with linearized
pHIPZ18_hasB and, after confirmation of hasB integration in transformants by colony PCR,
the pHIPH4_hasAs was inserted, resulting in strain EMB104 (Figure 2).
2.3. Media and Culture Conditions
Escherichia coli cells were cultured in lysogeny broth (LB) at 37 ◦C and 200 rpm. To se-
lect cells harboring plasmids, the medium was supplemented with ampicillin (100 µg/mL).
O. polymorpha strains were cultured and maintained in YPD (1% yeast extract, 2%
peptone, and 2% glucose) at 37 ◦C and 200 rpm. Transformant strains were selected and
maintained in media supplemented with 100 µg/mL zeocin or 300 µg/mL hygromycin,
according to the resistance markers.
2.4. Electrocompetent Cell Preparation and Transformation
The O. polymorpha electrocompetent cells were prepared as described previously [41],
using 175 mM β-mercaptoethanol in a substitution of dithiothreitol TED buffer. Sixty
microliters of the freshly prepared electrocompetent cells and 5–10 µg of the plasmid
linearized at the O. polymorpha promoter sequence with the appropriate restriction enzyme
were mixed and transferred into an ice-cold 2-m-gap electroporation cuvette. The pulse
was performed using a Bio-Rad Xcell MicroPulser cellular electroporator set to 50 µF,
129 Ω, and 1.5 kV (7.5 kV/cm). The recovered cells were plated onto selective media and
incubated at 37 ◦C.0020
2.5. Determination of the Growth Profile
Each constructed strain and the WT were grown overnight in YPD supplemented with
2% glucose and the appropriate antibiotics. On the following day, the cultures were used
to inoculate 500 mL baffled shake flasks containing 50 mL of YPD such that initial optical
density at 600 nm (OD600) was 0.3. Flasks were then incubated at 37 ◦C and 200 rpm for
biomass production. The cultures were monitored, and samples were taken every two
hours during the first 12 h for OD600 measurement using a SpectraMax M2 (Molecular
Devices®, San Jose, CA, USA). The cultures were started with glucose as the carbon source
as a step focused on producing biomass, thus decoupling growth from the heterologous
expression of the genes regulated by the pAOX promoter. Consequently, methanol had to
be added (1% at 7 and 21 h) to induce the heterologous expression of has genes.
At 25 h, cells were transferred to a fresh medium, since glucose is required to syn-
thesize both HA’s precursors (Figure 1). High-density cell cultures were harvested by
centrifugation (4000 rpm for 10 min) and transferred to 1-L baffled shake flasks containing
100 mL of medium and kept at 37 ◦C under agitation (200–250 rpm). The culture ended
after 24 h and samples were prepared for Scanning Electron Microscopy (SEM) analysis.
All cultures were performed twice.
The maximum growth rate (µMAX) was determined as the slope of the log-transformed
linear regression equation. The period of growth used was from 0 h to 6 h, which comprises
the exponential growth phase on glucose in the applied conditions.
2.6. Statistical Analysis and Data Presentation
The parameters µMAX (h−1), Final OD, and Doubling time (h), calculated from the
growth curves, and HA titer were submitted to analysis of variance (ANOVA) followed
by Tukey’s post-test using the Graphpad Prism software (version 6.0). The parameters
evaluated follow the criteria to choose the one-way ANOVA test. The growth curve in
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Figure 3 displays the average values obtained from two biological replicates, with the bars
representing the standard deviation (SD). All graphs were prepared using the Graphpad
Prism software (version 6.0). All genetic constructions represented in the figures presented
in the Supplementary Materials were obtained from the software SnapGene® version 5.1.5.
Figure 3. Growth profile of EMB102, EMB103, and EMB104 and O. polymorpha NCYC495 yku80 strain.
The experiment was performed in YPD, using shake flasks. The arrows indicate the approximate times
of supplementation with methanol to a final concentration of 1%. Means and standard deviations
were calculated from two biological replicates.
2.7. Analysis through Scanning Electron Microscopy (SEM)
Cells from 1 mL aliquots of cultures conducted as described above (Section 2.5) were
prepared for SEM as described in [11,42]. Images of the surfaces of the cells were made
on a Jeol JSM-7000F field emission scanning electron microscope with the assistance of an
Emitech K550 automated sputter coater and an Emitech K850 critical point dryer.
2.8. HA Quantification
The protocol applied for HA production and extraction was adapted from a previous
study [12]. Cells from each constructed strain and the WT were pre-grown overnight
in YPD medium supplemented with appropriate antibiotics, if needed. These cultures
were transferred to 1-L baffled shake flasks containing YPD and grown for 24 h aiming
a high-cell density culture. Additionally, methanol was added to 1% at 7 and 21 h for
induction of has genes, as described in Section 2.5. After the 24 h, cells were harvested and
washed using a saline solution (9 g/L of NaCl), then transferred to new 1-L baffled shake
flasks containing an optimized medium for HA production [43]: 4% glucose, 0.75% yeast
extract, 1% peptone, 0.25% K2HPO4, 0.05% MgSO4, 0.5% NaCl, 0.04% glutamine, 0.06%
glutamic acid, and 0.02% oxalic acid. Glucose was added to 2% during the cultivation to
avoid glucose-starvation as indicated by the OD600 measured. The cultivation ended after
48 h and cultures were prepared for HA quantification.
For HA extraction, 100 mL samples from each culture were purified as described
by [12]. Briefly, an equal volume of 0.1% (w/v) SDS solution was added, then the samples
were kept under orbital agitation for 10 min, so that the HA capsule was separated from
the cells after being centrifuged for 5 min at 4500× g. 1.5 volumes of ethanol were added
to the supernatant, which was incubated at 4 ◦C overnight, for at least 10 h. Then, samples
were centrifuged at 4500× g and 4 ◦C for 30 min. The pellet was washed with 25 mL of a
75% ethanol and 25% 0.15 M NaCl solution, then centrifuged once more. The supernatant
was discarded, and the pellet was incubated at room temperature and resuspended in
MilliQ water after the ethanol evaporated. The WT strain culture was used as a nega-
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tive control. The quantifications were performed in three technical replicates from each
biological replicate.
The carbazole method was used to quantify HA as previously described [44]. Firstly,
200 µL of water (blank), HA standard and purified samples were added to ice-cold glass
tubes with 500 µL of a 25 mM solution of sodium tetraborate in sulfuric acid. After
homogenizing, the tubes were incubated at 100 ◦C under agitation for 10 min and kept
at room temperature for cooling. Twenty µL of a 0.125% carbazole solution on methanol
was added to each tube. After a second incubation (100 ◦C for 15 min under agitation),
the samples were cooled to room temperature prior reading. The 200 µL volume of each
tube was applied to a 96-well microplate, which was read at 530 nm by the Biotek EON
microplate reader. The samples, as well as the points of the standard curve, were analyzed
in technical triplicate (Supplementary Materials, Figures S16 and S17). The ten-point
standard curve used comprised the concentrations of 10 µg/mL, 20 µg/mL, 50 µg/mL, 100
µg/mL, 200 µg/mL, 300 µg/mL, 400 µg/mL, 500 µg/mL, 600 µg/mL, and 700 µg/mL.
3. Results and Discussion
3.1. Strain Construction
Table 1 lists the strains developed in this study, including the promoters utilized for
each gene as well as the origin of the heterologous genes. Integration of synthetic constructs
into their genomes and their genetic stability were assessed through consecutive cultivation
in plates containing antibiotics, followed by PCR. Figures of the 1% agarose gels are shown
in Supplementary Materials (Figures S1–S5).
Table 1. Summary of all EMB strains constructed in this study.
EMB Strains PromoterDriving hasA Source of hasA
Promoter
Driving hasB Source of hasB
EMB102 pTEF1 P. multocida pAOX Xenopus laevis
EMB103 pADH1 P. multocida pGPD (S.cerevisiae) X. laevis
EMB104 pAOX S. zooepidemicus pADH1 X. laevis
The presence of hasB in strain EMB101 was confirmed by colony PCR. However, even
though EMB101 was capable of growing in the presence of the pHIPZ18 plasmid selection
marker, zeocin, the presence of hasAp was not detected by colony PCR after the third
passage in the selective medium (Supplementary Materials, Figure S2). For this reason,
EMB101 was not used in further experiments. Assessment of hasAp instability when inte-
grated into the ADH1 locus has not been investigated further. Both hasA and hasB could
be verified in strains EMB102, EMB103, and EMB104 (Supplementary Materials, Figures
S3–S5). For the strain EMB103, in which Int13 was used as a genetic switch to control the
expression of hasA and hasB, PCR analysis confirmed the rotation of both genes (Supple-
mentary Materials, Figure S4). Thus, these strains were used in subsequent experiments.
3.2. Growth Profile of Recombinant Strains
Decoupling cell growth and HA production is crucial to its synthesis. Thus, the culti-
vation was divided into two steps: biomass and enzymes production, and HA synthesis.
For the first step, the constructed strains EMB102, EMB103, and EMB104 as well the WT
strain were grown on shake flasks containing YPD aiming at achieving high-cell density
cultures (Figure 3). Since in the presence of glucose the pAOX promoter is repressed [23],
no HA synthesis is expected in this step. At the end of the exponential phase estimated by
the OD600 measured (7 h), methanol was added to the cultures to induce the expression of
has genes required for HA production. Methanol was also added at 21 h of cultivation to
ensure high levels of enzymes for HA production (Figure 3). Therefore, this first step of
cultivation comprised biomass production and accumulation of the enzymes required for
HA synthesis.
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While the strains had similar specific growth rate during the exponential phase, they
reached different final ODs (Table 2). Nevertheless, the highest mean of final OD, from the
WT strain, was statistically different only for the EMB104 strain (p < 0.05). This negative
impact on cell growth for the engineered strains could be related to (i) a high-level of
heterologous protein production after induction using methanol or (ii) production of HA,
which impacts cell growth. Indeed, the competition between HA production and cell
growth was previously described [6,28].
Table 2. The final OD600 and maximum specific growth rates (µMAX) from wild type and EMB strains as well as the HA
titer obtained by EMB strains when cultivated in shake flasks.
Strains µMAX (h−1) * Final OD * Doubling Time (h) * Hyaluronic Acid (HA)Titer (µg/mL) ** Final OD **
WT 0.50 ± 0.02 a 38.00 ± 3.46 a 1.35 ± 0.06 a NA 21.00 ± 1.41 a
EMB102 0.45 ± 0.04 a 27.50 ± 3.54 a,b 1.55 ± 0.15 a 151.20 ± 13.04 a,b 27.00 ± 0.00 a
EMB103 0.52 ± 0.01 a 30.00 ± 4.24 a,b 1.34 ± 0.01 a 197.76 ± 5.66 b 27.50 ± 0.71 a
EMB104 0.49 ± 0.02 a 24.50 ± 2.12 b 1.41 ± 0.07 a 123.20 ± 26.56 a 21.50 ± 3.54 a
NA: Not applied. Equal letters indicate no statistical difference between the strains (p < 0.05). * Parameters were calculated based on the
data obtained by the growth curves presented in Figure 3 and described in Material and Methods (Section 2.5). ** Values were obtained
after 48 h of cultivation in medium optimized for HA production [12,43].
For the K. lactis HA-producing yeast, HA production had a negative impact on final
cell density [11]. This might be linked to the fact that the HA precursor UDP-GlcNAc is a
cell wall component for yeasts, and thus, HA synthesis competes with biomass formation.
As methanol is necessary for the expression of the HA synthesis enzymes on the constructed
strains, the competition between biomass and HA production only becomes noticeable
after the addition of methanol.
After the first phase of growth for biomass generation and induction of has genes
(Figure 3), the entire culture was transferred to fresh YPD medium, aiming at HA produc-
tion. In this case, the production was assessed by SEM.
3.3. HA Production Assessed by Scanning Electron Microscopy Analysis
Given that HA is produced and secreted by the cells, a capsular structure can be
visualized on their surface. This method was reported previously to confirm the production
of HA by L. lactis [45] and by the yeast K. lactis [11]. The formation of a capsule-like layer
was also observed in HA-producing strains of C. glutamicum [46], although a phase-contrast
microscopy analysis was applied instead of SEM. In this case, the capsule-like layer affected
nutrient uptake and cell metabolism, which impaired HA production [46].
As seen on SEM images from 24 h cultures, WT cells are clearly discrete, with separate
cell walls and moderate aggregation. Cells from the EMB102 and EMB104 strains showed
no significant superficial differences compared to the WT strain, although a discrete capsule-
like structure was observed (Figure 4B). Strain EMB103 is clearly distinct from the others.
Firstly, discrete cell walls between cells are not distinguishable at the same magnification
as in the other strains (Figure 4B). Likewise, seemingly intensified aggregation is observed,
and free individual cells are less common. Lastly, EMB103 cells seem to be covered in a
substance that glues them together and generates an irregular cell surface indicating the
production of HA (Figure 5).
The EMB103 strain was constructed containing a genetic switch for the expression of
hasAp and hasB which allows expression of both genes after the induction of a gene encoding
a serine-like integrase-13. Thus, the formation of a capsule-like layer by the EMB103 cells
indicates the genetic switch constructed for O. polymorpha works properly. Recently, the
utilization of integrases to design genetic circuits for gene regulation is emerging as a
powerful synthetic biology tool [31]. Serine integrases are also used as a genetic tool to
mediate in vivo site-specific recombination between an exogenous DNA fragment, such as
plasmids or gene expression cassettes, into a target genome [47]. This has become a versatile
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system since its application was demonstrated in prokaryotes [48] and higher eukaryotes
such as human, bovine, and plant cells [32]. For yeast cells, several integrases showed
activity when expressed by S. cerevisiae, with the highest activity reached by the φBT1
integrase [49]. Additionally, the authors verified no site damage by integrase-mediated
recombination, which is important to reduce point mutations during the site-specific
recombination events. In another study using baker’s yeast, the PhiC31 integrase was used
to successfully recycle the selective markers HIS5 and LEU2 [50]. However, it was verified
that the system was efficient only when a low-copy vector bearing the integrase-encoding
gene was used, probably due to the toxicity of PhiC31 integrase. The Int13 utilized in
this study showed no point mutation or impact on cell viability when tested in different
eukaryotic cells [23], representing a reliable genetic tool for yeast cells. Nevertheless,
there is no report of a genetic switch using serine integrases for gene regulation in non-
conventional yeasts. Here, as a proof of concept, the system was applied to construct an
O. polymorpha strain that produces HA and showed to be the best genetic approach for
constructing HA producing O. polymorpha strains.
Figure 4. Scanning Electron Microscopy of different O. polymorpha strains. The names above the
image correspond to the respective strain. Images were acquired at two magnifications: (A) 2000×
and (B) 5500×.
Figure 5. Scanning Electron Microscopy of Wild Type (WT) (A) and EMB103 (B) in the magnitude of
11,000×.
3.4. HA Quantification
Since a discrete difference between the cell surface of EMB102 and EMB104 compared
to the WT was observed, it was hypothesized that HA production could be limited by
growth conditions as well as the HA purification protocol applied. Therefore, an adaptation
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from the previous protocol applied for K. phaffi was performed [12], which is an optimized
medium for HA. By this approach, it was possible to quantify the HA in the supernatant
from all constructed strains (Table 2). After 48 h of culture, HA titers were assessed through
the carbazole method, which was able to accurately quantify the production of HA (Table 2
and Supplementary Materials, Figure S17).
The highest titer of HA (197.76 µg/mL) was achieved by strain EMB103, although
its result is not statistically different from that of the EMB102 strain (151.20 µg/mL).
The EMB104 strain achieved the lowest HA concentration in the study (123.20 µg/mL).
Furthermore, both HAS encoding genes (hasAp and hasAs) seem to work properly in
O. polymorpha, indicating that this yeast is a suitable host platform for the application of
different strategies for HA production.
Apparently, HA production in O. polymorpha in the conditions applied is limited
leading to a low synthesis by all strains. Nevertheless, these results demonstrate the
potential of O. polymorpha as a platform host for HA production, although the process
requires optimization regarding cell cultivation. For instance, for the K.phaffi HA-producing
strain, cultivation was performed in fermenters using a fed-batch mode with controlled
dissolved oxygen levels and only 200 mg/L of HA was detected after 48 h of culture when
both hasA and hasB were expressed [12]. Therefore, the conditions used here to produce,
and isolate HA are sub-optimal. Furthermore, the purification of HA was conducted solely
on the supernatant of cultures. Yet, it has been determined that the HAS enzyme from
P. multocida serogroup A:1, differently from other HAS, is actually cytosolic and does not
possess an HA exporting function [51]. Indeed, there is published evidence of up to 80% of
heterologously produced HA inside of algae host cells [52]. While it is established that HA
is secreted to the extracellular medium simultaneously with its synthesis by streptococcal
HAS enzymes, strains EMB 102 and EMB 103, harboring the hasAp gene, might still produce
intracellular HA. This evidence suggests that lysates of cultured cells might also be sources
for HA quantification and their use in quantification in addition to the supernatant should
be considered, depending on the experimental setup and enzymes used.
Additionally, the balance between the two precursors plays a key role in HA pro-
duction [53,54]. Intracellular concentrations of precursors present a challenge for HA
production, and equimolar concentration of UDP-GlcNAc and UDP-GlcUA is required
for efficient synthesis of HA. In this regard, the availability of UDP-GlcNAc presents a
hurdle, for it is diverted to cell wall formation in O. polymorpha [55]. Lastly, the Pentose
Phosphate Pathway (PPP) deviates Glucose-6-phosphate which is required for HA precur-
sors biosynthesis. Downregulation of the zwf gene, which encodes for the first enzyme of
PPP, is a well-described strategy for improving HA production [8,9,56]. The O. polymorpha
NCYC495 strain, when grown at temperatures above 30 ◦C, showed an increased flux to-
wards PPP higher than the other thermotolerant yeast tested, Kluyveromyces marxianus [57].
It is worth mentioning that PPP and methanol assimilation are intrinsically related in
Ogataea sp. [58] as well as in other methylotrophic yeasts [59]. Xylulose-5-phosphate, an
intermediate from PPP, is required for methanol assimilation, specifically for formaldehyde
fixation by the enzyme dihydroxyacetone synthase (Figure 1). In fact, in O. parapolymorpha
(previously known as Hansenula polymorpha DL-1), genes encoding enzymes from the
non-oxidative phase of PPP are upregulated in the presence of methanol [58]. Therefore,
PPP flux is an important bottleneck to be considered for the heterologous production of HA
by O. polymorpha. Strategies aiming at funneling the metabolic framework of O. polymorpha
are required to ensure a proper flux through HA precursors and its efficient synthesis.
Nevertheless, the production of up to 197.76 µg/mL of HA by O. polymorpha has been
reported, demonstrating the potential of this non-conventional yeast for production of HA,
although several aspects of the process require further optimization, as discussed above.
4. Conclusions
O. polymorpha was engineered for HA production. Both hasB (X. laevis) and two differ-
ent hasA genes, from P. multocida (hasAp) and S. zooepidemicus (hasAs), were successfully
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integrated into the O. polymorpha genome under the control of different promoters. Addi-
tionally, a genetic switch using a serine-type integrase-13 to control the expression of both
hasAp and hasB was demonstrated. Both the qualitative and quantitative methods were
able to show HA synthesis by the yeast. The capsule-like structure observed in EMB103
cells by SEM analysis indicates HA production by this strain. Indeed, the EMB103 was
able to produce 197.76 µg/mL, which is considered a low HA titer. Additionally, it was
demonstrated that both HAS encoding genes from P. multocida and S. zooepidemicus can be
utilized in O. polymorpha, which enables the design of different strategies for HA production
in this industrial yeast. These results demonstrate not only the potential of O. polymorpha as
a host platform for HA production but also of integrases for gene regulation in this yeast.
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Plasmid maps; Figure S16: Carbazole standard curve; Figure S17: Carbazole assay plate picture.
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